TAMPA, Fla., March 11, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR), a company dedicated to pet health and wellness, has officially signed a binding Letter of Intent (LOI) to acquire 100% of Choice Specialty Pharmacy Group. This strategic move is set to enhance Better Choice’s specialty pharmacy services across the United States.
The acquisition agreement, which is based on 6X of Choice Specialty’s fiscal year 2024 Adjusted EBITDA of roughly USD 4.68 million, will be financed through a combination of stock and cash at closing. Michael Young, the Chairman of Better Choice, stated, ‘With the addition of Choice Specialty Pharmacy Group alongside our SRx platform in Canada, we are now executing on our strategy to build a healthcare services company with significant market share in North America.’
Established in 2015, Choice Specialty Pharmacy Group is known for its comprehensive pharmacy services, including specialty pharmacy, infusion clinic services, and operation of a sterile compounding facility across multiple states. The acquisition is expected to further solidify Better Choice’s commitment to leading the North American healthcare services market and delivering high-quality patient care.
Better Choice Company focuses on providing innovative, nutrition-based products and services for pets. With this acquisition, the company aims to expand its geographical presence while leveraging operational efficiencies and best practices from both organizations, thus ensuring better consumer services in the growing healthcare landscape.
For more information, visit Better Choice Company.
Comments are closed